175 related articles for article (PubMed ID: 20700772)
1. Gene transfer to the cerebellum.
Louboutin JP; Reyes BA; Van Bockstaele EJ; Strayer DS
Cerebellum; 2010 Dec; 9(4):587-97. PubMed ID: 20700772
[TBL] [Abstract][Full Text] [Related]
2. Strategies for CNS-directed gene delivery: in vivo gene transfer to the brain using SV40-derived vectors.
Louboutin JP; Reyes BA; Agrawal L; Van Bockstaele E; Strayer DS
Gene Ther; 2007 Jun; 14(12):939-49. PubMed ID: 17443215
[TBL] [Abstract][Full Text] [Related]
3. Gene transfer to the rhesus monkey brain using SV40-derived vectors is durable and safe.
Louboutin JP; Marusich E; Fisher-Perkins J; Dufour JP; Bunnell BA; Strayer DS
Gene Ther; 2011 Jul; 18(7):682-91. PubMed ID: 21368898
[TBL] [Abstract][Full Text] [Related]
4. Rat bone marrow progenitor cells transduced in situ by rSV40 vectors differentiate into multiple central nervous system cell lineages.
Louboutin JP; Liu B; Reyes BA; Van Bockstaele EJ; Strayer DS
Stem Cells; 2006 Dec; 24(12):2801-9. PubMed ID: 16960137
[TBL] [Abstract][Full Text] [Related]
5. Delivering genes to the organ-localized immune system: long-term results of direct intramarrow transduction.
Louboutin JP; Liu B; Chekmasova AA; Reyes BA; van Bockstaele EJ; Strayer DS
J Gene Med; 2007 Oct; 9(10):843-51. PubMed ID: 17694566
[TBL] [Abstract][Full Text] [Related]
6. Antioxidant enzyme gene delivery to protect from HIV-1 gp120-induced neuronal apoptosis.
Agrawal L; Louboutin JP; Reyes BA; Van Bockstaele EJ; Strayer DS
Gene Ther; 2006 Dec; 13(23):1645-56. PubMed ID: 16871233
[TBL] [Abstract][Full Text] [Related]
7. In vivo gene transfer into rat bone marrow progenitor cells using rSV40 viral vectors.
Liu B; Daviau J; Nichols CN; Strayer DS
Blood; 2005 Oct; 106(8):2655-62. PubMed ID: 15994284
[TBL] [Abstract][Full Text] [Related]
8. Using gene delivery to protect HIV-susceptible CNS cells: inhibiting HIV replication in microglia.
Cordelier P; Strayer DS
Virus Res; 2006 Jun; 118(1-2):87-97. PubMed ID: 16414141
[TBL] [Abstract][Full Text] [Related]
9. In vivo transduction of murine cerebellar Purkinje cells by HIV-derived lentiviral vectors.
Torashima T; Okoyama S; Nishizaki T; Hirai H
Brain Res; 2006 Apr; 1082(1):11-22. PubMed ID: 16516872
[TBL] [Abstract][Full Text] [Related]
10. Efficient gene transfer to hematopoietic progenitor cells using SV40-derived vectors.
Strayer DS; Pomerantz RJ; Yu M; Rosenzweig M; BouHamdan M; Yurasov S; Johnson RP; Goldstein H
Gene Ther; 2000 May; 7(10):886-95. PubMed ID: 10845727
[TBL] [Abstract][Full Text] [Related]
11. Protecting neurons from HIV-1 gp120-induced oxidant stress using both localized intracerebral and generalized intraventricular administration of antioxidant enzymes delivered by SV40-derived vectors.
Louboutin JP; Agrawal L; Reyes BA; Van Bockstaele EJ; Strayer DS
Gene Ther; 2007 Dec; 14(23):1650-61. PubMed ID: 17914406
[TBL] [Abstract][Full Text] [Related]
12. Inhibiting AIDS in the central nervous system: gene delivery to protect neurons from HIV.
Cordelier P; Van Bockstaele E; Calarota SA; Strayer DS
Mol Ther; 2003 Jun; 7(6):801-10. PubMed ID: 12788654
[TBL] [Abstract][Full Text] [Related]
13. Durability of transgene expression and vector integration: recombinant SV40-derived gene therapy vectors.
Strayer D; Branco F; Zern MA; Yam P; Calarota SA; Nichols CN; Zaia JA; Rossi J; Li H; Parashar B; Ghosh S; Chowdhury JR
Mol Ther; 2002 Aug; 6(2):227-37. PubMed ID: 12161189
[TBL] [Abstract][Full Text] [Related]
14. In vivo gene transfer to the CNS using recombinant SV40-derived vectors.
Louboutin JP; Agrawal L; Liu B; Strayer DS
Expert Opin Biol Ther; 2008 Sep; 8(9):1319-35. PubMed ID: 18694352
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 gp120-induced neuroinflammation: relationship to neuron loss and protection by rSV40-delivered antioxidant enzymes.
Louboutin JP; Reyes BA; Agrawal L; Van Bockstaele EJ; Strayer DS
Exp Neurol; 2010 Jan; 221(1):231-45. PubMed ID: 19913017
[TBL] [Abstract][Full Text] [Related]
16. SV40-derived vectors provide effective transgene expression and inhibition of HIV-1 using constitutive, conditional,and pol III promoters.
Jayan GC; Cordelier P; Patel C; BouHamdan M; Johnson RP; Lisziewicz J; Pomerantz RJ; Strayer DS
Gene Ther; 2001 Jul; 8(13):1033-42. PubMed ID: 11438838
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy using SV40-derived vectors: what does the future hold?
Strayer DS
J Cell Physiol; 1999 Dec; 181(3):375-84. PubMed ID: 10528223
[TBL] [Abstract][Full Text] [Related]
18. SV40-based gene therapy vectors: turning an adversary into a friend.
Strayer DS
Curr Opin Mol Ther; 2000 Oct; 2(5):570-8. PubMed ID: 11249759
[TBL] [Abstract][Full Text] [Related]
19. Gene transfer to the spinal cord neural scar with lentiviral vectors: predominant transgene expression in astrocytes but not in meningeal cells.
Hendriks WT; Eggers R; Verhaagen J; Boer GJ
J Neurosci Res; 2007 Nov; 85(14):3041-52. PubMed ID: 17671987
[TBL] [Abstract][Full Text] [Related]
20. Simian virus-40 as a gene therapy vector.
Vera M; Fortes P
DNA Cell Biol; 2004 May; 23(5):271-82. PubMed ID: 15169607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
